Indolent

In clinical and pathological contexts, 'indolent' refers to a condition—most often a neoplasm—that grows slowly, has low metastatic potential, and causes few or no symptoms over an extended period, as opposed to 'aggressive' diseases that progress rapidly. Indolent lymphomas (e.g., follicular lymphoma, marginal zone lymphoma, small lymphocytic lymphoma/CLL) typically have low proliferation indices (e.g., low Ki-67), may not require immediate treatment (watchful waiting), and have better short-term prognosis but are often incurable with conventional chemotherapy due to their slow-cycling nature, making them resistant to agents targeting rapidly dividing cells. Paradoxically, indolent cancers can sometimes be harder to cure than aggressive ones because standard chemotherapeutics target actively dividing cells. Indolent ulcers (e.g., in tuberculosis, stasis ulcers, or certain skin conditions) are characterized by minimal pain, slow healing, and a chronic, non-healing course. The term can also apply to chronic infections with low-grade, smoldering inflammation and minimal acute symptoms. Clinically, recognizing indolent behavior influences management decisions—often favoring observation over aggressive intervention—particularly in older patients or those with significant comorbidities, as the natural disease course may not significantly impact survival or quality of life in the short term.